Comment from Critical Path Institute

Summary: The Critical Path Institute (C-Path), a nonprofit organization, supports the FDA's initiative on patient-focused drug development (PFDD) meetings. They provide detailed examples of how these meetings have identified scientific gaps, informed clinical trial designs, and improved patient engagement for conditions like Polycystic Kidney Disease and Alpha-1 Antitrypsin Deficiency.